Samrat Pharmachem Ltd.
| BSE: 530125 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE103E01016 |
| BSE 00:00 | 05 Jul | 452.40 |
11.25 (2.55%) |
OPEN
449.90 |
HIGH
459.30 |
LOW
433.00 |
| NSE 05:30 | 01 Jan | Samrat Pharmachem Ltd |
| OPEN | 449.90 |
| PREVIOUS CLOSE | 441.15 |
| VOLUME | 3602 |
| 52-Week high | 578.00 |
| 52-Week low | 170.00 |
| P/E | 8.13 |
| Mkt Cap.(Rs cr) | 140 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Samrat Pharmachem Ltd. (SAMRATPHARMA) - Cash Flow
| Figures in Rs crore | 2021 | 2020 | 2019 |
| Opening Cash & Cash Equivalents | 0.26 | 1.50 | 0.87 |
| Net Cash From Operating Activities | 4.83 | -1.33 | 2.37 |
| Net Cash Used In/from Investing Activities | -2.92 | -1.92 | 2.18 |
| Net Cash Used In/from Financing Activities | -1.89 | 2.00 | -3.92 |
| Net (decrease)/increase In Cash and Cash Equivalents |
0.02 | -1.25 | 0.63 |
| Closing Cash & Cash Equivalents | 0.28 | 0.26 | 1.50 |
Quick Links for Samrat Pharmachem:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
